79 related articles for article (PubMed ID: 25503472)
1. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
Che JP; Li W; Yan Y; Liu M; Wang GC; Li QY; Yang B; Yao XD; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2300-11. PubMed ID: 24228091
[TBL] [Abstract][Full Text] [Related]
3. Nin one binding protein expression as a prognostic marker in prostate carcinoma.
Liu G; Shen D; Jiao L; Sun Y
Clin Transl Oncol; 2014 Sep; 16(9):843-7. PubMed ID: 24493285
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
6. EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.
Zhou WP; Liu X; Yang Y; Liu YF
J Biol Regul Homeost Agents; 2015; 29(2):423-30. PubMed ID: 26122232
[TBL] [Abstract][Full Text] [Related]
7. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
8. AP‑4 predicts poor prognosis in non‑small cell lung cancer.
Gong H; Han S; Yao H; Zhao H; Wang Y
Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
10. [Expression of NOB1 and its significance in colorectal cancer].
Wu DP; He XW
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):420-2. PubMed ID: 22445998
[TBL] [Abstract][Full Text] [Related]
11. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.
Zhang X; Zhang D; Qu F; Hong Y; Cao J; Pan X; Li L; Huang Y; Huang H; Yin L; Chen L; Ren J; Wang Z; Xu D; Cui X
Mol Cell Biochem; 2014 Nov; 396(1-2):1-8. PubMed ID: 25169742
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma.
Li XY; Luo QF; Li J; Wei CK; Kong XJ; Zhang JF; Fang L
Int J Clin Exp Pathol; 2013; 6(10):2137-44. PubMed ID: 24133592
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of NIN/RPN12 binding protein inhibits proliferation and growth in human renal cancer cells.
Jia JW; Liu AQ; Wang Y; Zhao F; Jiao LL; Tan J
Tumour Biol; 2015 Mar; 36(3):1803-10. PubMed ID: 25420906
[TBL] [Abstract][Full Text] [Related]
16. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract][Full Text] [Related]
17. [Expression of nucleostemin in prostate cancer tissues and its clinical significance].
Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Qi SY; Zhang Y; Li SZ
Zhonghua Nan Ke Xue; 2008 May; 14(5):418-22. PubMed ID: 18572860
[TBL] [Abstract][Full Text] [Related]
18. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma.
Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G
J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression and characterization of the human NOB1 gene.
Zhang Y; Ni J; Zhou G; Yuan J; Ren W; Shan Y; Tang W; Yu L; Zhao S
Mol Biol Rep; 2005 Sep; 32(3):185-9. PubMed ID: 16172919
[TBL] [Abstract][Full Text] [Related]
20. C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance.
Meng J; Wang LH; Zou CL; Dai SM; Zhang J; Lu Y
Med Sci Monit; 2017 Oct; 23():5176-5183. PubMed ID: 29084195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
